<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Digital Pathology News | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/category/digital-pathology-news/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Fri, 01 May 2026 12:32:48 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>Digital Pathology News | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Techcyte announces $15 Million Capital Raise Led by Van Tuyl Companies to Support Growth and Path to Profitability</title>
		<link>https://tissuepathology.com/2026/05/01/techcyte-announces-15-million-capital-raise-led-by-van-tuyl-companies-to-support-growth-and-path-to-profitability/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 01 May 2026 12:32:48 +0000</pubDate>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[capital]]></category>
		<category><![CDATA[Mayo Clinic]]></category>
		<category><![CDATA[Techcyte]]></category>
		<category><![CDATA[Van Tuyl Companies]]></category>
		<category><![CDATA[Zoetis Inc.]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24390</guid>

					<description><![CDATA[<p>Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced the completion of a $15 million capital raise led by Van Tuyl Companies, with participation from existing investors Zoetis Inc. (“Zoetis”) and Mayo Clinic. This funding reinforces Techcyte’s ability to execute on its strategic priorities and supports its path to [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/05/01/techcyte-announces-15-million-capital-raise-led-by-van-tuyl-companies-to-support-growth-and-path-to-profitability/">Techcyte announces $15 Million Capital Raise Led by Van Tuyl Companies to Support Growth and Path to Profitability</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>What’s New in Glencoe Software’s PathViewer 3.16.1</title>
		<link>https://tissuepathology.com/2026/04/30/whats-new-in-glencoe-softwares-pathviewer-3-16-1/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Thu, 30 Apr 2026 13:30:19 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Clinical Laboratories]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Glencoe Software]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[software update]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24388</guid>

					<description><![CDATA[<p>From the Glencoe Software blog We are excited to announce the release of PathViewer 3.16.1! This version introduces enhanced mask support, improved channel controls, and expanded dataset-level annotation customization. Auto-Min/Max Channel Control An auto-min/max button has been added to the Viewing Options channel controls, allowing all visible channels to be scaled to their histogram range [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/04/30/whats-new-in-glencoe-softwares-pathviewer-3-16-1/">What’s New in Glencoe Software’s PathViewer 3.16.1</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>EVIDENT Announces 6th Annual Image of the Year Award Winners</title>
		<link>https://tissuepathology.com/2026/04/29/evident-announces-6th-annual-image-of-the-year-award-winners/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 29 Apr 2026 13:25:16 +0000</pubDate>
				<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Microscopy]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[EVIDENT]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Image of the Year]]></category>
		<category><![CDATA[scientific microscopic imaging]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24385</guid>

					<description><![CDATA[<p>EVIDENT: Star-like neurospheres brilliantly connect our inner and outer worlds NEEDHAM, Mass., April 28, 2026 (GLOBE NEWSWIRE) &#8212; Evident unveiled the winners of its sixth annual Image of the Year contest, an awards competition that recognizes the world’s best in scientific microscopic imaging. The winners were selected from submissions from 34 countries around the world. Global [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/04/29/evident-announces-6th-annual-image-of-the-year-award-winners/">EVIDENT Announces 6th Annual Image of the Year Award Winners</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>HistoIndex Extends Access To Its MASH Diagnostic Offering Through New Partnerships In Texas And California</title>
		<link>https://tissuepathology.com/2026/04/28/histoindex-extends-access-to-its-mash-diagnostic-offering-through-new-partnerships-in-texas-and-california/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 28 Apr 2026 11:50:17 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[chronic liver disease]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Histoindex]]></category>
		<category><![CDATA[Houston Research Institute]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Knowledge Research Center]]></category>
		<category><![CDATA[M*A*S*H]]></category>
		<category><![CDATA[Metabolic Dysfunction-Associated Steatohepatitis]]></category>
		<category><![CDATA[Pathology]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24383</guid>

					<description><![CDATA[<p>SINGAPORE, April 28, 2026 /PRNewswire/ &#8212; HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced the continued expansion of its commercial partnership network in the United States with the addition of two new hepatology and gastroenterology centers &#8211; Houston Research Institute (HRI) Kingwood and Knowledge Research Center (KRC) in Orange, California. HistoIndex [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/04/28/histoindex-extends-access-to-its-mash-diagnostic-offering-through-new-partnerships-in-texas-and-california/">HistoIndex Extends Access To Its MASH Diagnostic Offering Through New Partnerships In Texas And California</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Fimlab expands utilization of Aiforia&#8217;s clinical AI solutions</title>
		<link>https://tissuepathology.com/2026/04/27/fimlab-expands-utilization-of-aiforias-clinical-ai-solutions/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 27 Apr 2026 12:10:53 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Clinical Laboratories]]></category>
		<category><![CDATA[Clinical Pathology]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Aiforia]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Fimlab]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24380</guid>

					<description><![CDATA[<p>Fimlab Laboratories expands the use of Aiforia’s AI solutions for breast cancer diagnostics, bringing multi-organ Ki67 biomarker quantification into routine clinical use. Aiforia Technologies Plc, Press Release, April 27, 2026 at 9:00 a.m. EEST Aiforia Technologies Plc announced today that Fimlab Laboratories in Finland has expanded the use of Aiforia’s AI solutions in routine clinical [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/04/27/fimlab-expands-utilization-of-aiforias-clinical-ai-solutions/">Fimlab expands utilization of Aiforia’s clinical AI solutions</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026</title>
		<link>https://tissuepathology.com/2026/04/24/panakeia-unveils-landmark-metabolic-and-pathway-activation-data-in-cancers-at-aacr-2026/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 24 Apr 2026 12:37:33 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Clinical Laboratories]]></category>
		<category><![CDATA[Clinical Pathology]]></category>
		<category><![CDATA[Conferences]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Education]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AACR 2026]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[American Association for Cancer Research]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[metabolic pathways]]></category>
		<category><![CDATA[Panakeia]]></category>
		<category><![CDATA[Pathology]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24377</guid>

					<description><![CDATA[<p>CAMBRIDGE, UK — April 21, 2026 — Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual Meeting 2026, further proving its unique capability to unlock complete biological blueprints essential for drug discovery and clinical decision-making. The Company revealed [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/04/24/panakeia-unveils-landmark-metabolic-and-pathway-activation-data-in-cancers-at-aacr-2026/">Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
